Uterine artery embolization (UAE) for fibroids may cause ovarian dysfunction, particularly concerning for reproductive-aged women. This study evaluated whether a structured telemedicine follow-up protocol enhances timely identification of early-stage ovarian dysfunction compared to traditional outpatient care, thereby expanding the therapeutic intervention window. This retrospective cohort study analyzed 232 women aged 18–40 who underwent UAE at Fujian Maternity and Child Health Hospital (December 2020–2023). Participants were assigned to WeChat telemedicine platform (n = 138) or traditional follow-up (n = 94). Primary outcome was early identification of ovarian dysfunction, defined as diminished ovarian reserve (AMH < 1.1 ng/ml, FSH 10-15 IU/L), or subclinical POI (FSH 15-25 IU/L). Secondary outcomes included hormone replacement therapy adherence and quality of life scores. Telemedicine significantly improved early detection of ovarian dysfunction (21% vs 3%, p < 0.001), particularly in women aged 28–36 (OR = 7.84, 95%CI: 1.05–58.44). Follow-up completion increased substantially (3.83 ± 0.60 vs 2.67 ± 1.04 visits, p < 0.001). Among patients with confirmed dysfunction, telemedicine achieved superior hormone therapy adherence (82.8% vs 27.3% good adherence, p < 0.001) and better quality of life scores at 3 months (MENQOL: 49.83 ± 10.82 vs 59.09 ± 15.30, p = 0.038). Telemedicine follow-up after UAE significantly is significantly associated with early detection of ovarian dysfunction and treatment adherence. Integration of structured remote monitoring protocols into post-UAE care pathways may improve long-term reproductive health outcomes.
Zheng et al. (2026) studied this question.